Journal September 25, 2026 4 min read

Which peptides are studied in relation to UCP1?

A research-supply overview of the peptides and related compounds investigated alongside UCP1 and adipose thermogenesis, including follistatin, GDF-11, and reference-only findings in animal and in vitro models.

peptides-pro Editorial

UCP1 (uncoupling protein 1, also called thermogenin) is the inner-mitochondrial-membrane protein that defines brown and beige adipocytes, and the peptides most frequently studied in relation to it are members of the TGF-β superfamily — principally follistatin (FST) and growth differentiation factor 11 (GDF-11) — together with a set of reference-only compounds examined for their effects on thermogenic gene programs. UCP1 is not itself a peptide; it is the downstream marker against which peptide and small-molecule interventions are scored in adipose tissue models.

The work centres on the TGF-β/SMAD signalling axis and its cross-talk with adrenergic and SIRT1-linked pathways that converge on the UCP1 transcriptional program in brown adipose tissue (BAT) and in browning white adipose tissue (WAT).

Research Studies

Follistatin and adipose browning in mouse models

Follistatin binds and neutralizes members of the TGF-β superfamily, a mechanism that regulates skeletal muscle, adipose and bone homeostasis. In mice, FST promoted adipose browning and enhanced energy metabolism, with improved plasma lipid profiles and metabolic health. Transcriptomic and metabolomic analysis of the Hybrid Mouse Diversity Panel found that Fst expression was negatively correlated with aortic lesion area, and the authors investigated the anti-atherogenic potential of FST against the background of BAT activation and reduced atherosclerosis [1].

GDF-11 and cold-induced browning of white adipose tissue

GDF-11 is a circulating TGF-β superfamily member. In mice exposed to cold to induce browning, GDF-11 expression and SMAD2/3 activation were assessed in BAT, visceral and subcutaneous WAT, and skeletal muscle. The study combined in vivo results with in vitro approaches in 3T3-L1 cells to test whether GDF-11 regulates WAT browning and by what mechanism [2].

Finerenone and epicardial adipose tissue characteristics

Finerenone is a nonsteroidal mineralocorticoid receptor antagonist with anti-inflammatory, antifibrotic and metabolic effects. Preclinical studies suggest it promotes browning of adipose tissue and improves epicardial adipose tissue (EAT) characteristics. A single-centre, randomized, investigator-blinded pilot trial is enrolling 40 patients to test finerenone after catheter ablation for atrial fibrillation recurrence, a setting in which EAT biology is of interest [3].

Exercise and diet interventions and adipose tissue functionality

A registered study in middle-aged volunteers with metabolic syndrome is designed to test whether physical exercise and/or a Mediterranean diet preserve adipose tissue functionality and retard skeletal muscle ageing, assessed by mitochondrial biogenesis and reactive oxygen species accumulation, through pathways homologous to caloric restriction [4].

Syringaresinol and the skeletal muscle SIRT1–FNDC5/irisin axis

Syringaresinol (SYR), a plant-derived lignan, was examined for modulation of skeletal muscle SIRT1-related FNDC5/irisin signalling and high-fat-diet-associated metabolic outcomes. Differentiated C2C12 myotubes were treated with SYR, the SIRT1 activator SRT1720, and the SIRT1 inhibitor EX-527 to assess irisin-related readouts [5]. This is an in vitro skeletal muscle model; UCP1 is not the primary endpoint.

Time-restricted feeding and HIIT in diabetic rats

An animal study evaluated the independent and combined effects of time-restricted feeding and high-intensity interval training on thermogenesis-related protein abundance in white adipose tissue of diabetic rats. Forty male Wistar rats were divided into normal and diabetic groups [6]. This is animal-only evidence.

β2-adrenergic receptor stimulation in human adipose-derived stem cells

β-adrenergic receptors drive induction of beige adipocytes in rodents and humans, but whether β2-AR or β3-AR is the dominant human subtype remains debated. This study tested whether human adipose-derived mesenchymal stem cell (hADSC)-derived adipocytes can serve as a beiging-competent model under human-relevant conditions [7]. This is an in vitro human cell model.

Bombesin receptor-activated protein homolog and metabolic dysfunction

Bombesin receptor-activated protein (BRAP) and its mouse homolog BC004004 are expressed in the central nervous system. In feeding experiments, BRAP homolog knockout mice (BC004004^-/-) showed reduced preference for a high-fat diet, and the work examined food intake and metabolic dysfunction in high-fat-diet-treated mice [8]. This is animal-only evidence.

Comparison of evidence contexts

Compound or intervention	Model	UCP1-relevant context
Follistatin (FST)	Mice; HMDP transcriptomics	Adipose browning, energy metabolism, aortic lesion area [1]
GDF-11	Mice; 3T3-L1 in vitro	Cold-induced WAT browning, SMAD2/3 activation [2]
Finerenone	Human pilot trial (planned)	Preclinical browning and EAT effects cited as rationale [3]
Exercise / Mediterranean diet	Human volunteers	Adipose functionality, mitochondrial biogenesis [4]
Syringaresinol	C2C12 myotubes	SIRT1–FNDC5/irisin axis, not UCP1-primary [5]
TRF + HIIT	Diabetic rats	Thermogenesis-related protein abundance in WAT [6]
β2-AR stimulation	Human hADSC-derived adipocytes	Beige differentiation model [7]
BRAP homolog knockout	Mice	Food intake, metabolic dysfunction [8]

If you are reading this for personal health reasons

The materials described here are sold for laboratory research use only. We do not provide dosing, administration or medical guidance of any kind. Anyone considering a compound for themselves should speak to a licensed clinician.